New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
LeMaitre Vascular, Inc.
LMAT
Shape
US Flag

NASDAQ

2B

Medical - Instruments & Supplies

Next Earning date - 31 Oct 2024

2B

Medical - Instruments & Supplies

Next Earning date - 31 Oct 2024

85.64USD
Shape-0.94 ( -1.09%)
favorite-chart

Relative Strenght

83
favorite-chart

Volume Buzz

-27%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

8%

Quote Panel

Shape
Updated October 27, 2024
1W -3.36 % 1M -7.80 % 3M -1.78 % 1Y 80.41 %

Key Metrics

Shape
  • Market Cap

    1.92B


  • Shares Outstanding

    22.47M


  • Share in Float

    20.47M


  • Dividende

    0.64


  • Earning Date

    31 Oct 2024


  • Price Target

    85.64


  • Average Volume

    116014


  • Beta

    0.877


  • Range

    44.27-93.32


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.lemaitre.com


  • Sector

    Healthcare


Fundamentals

Shape

51.28x

P/E Ratio

9.36x

P/S Ratio

6.02x

P/B Ratio

0.1

Debt/Equity

18.3%

Net Margin

$1.7

EPS

How LMAT compares to sector?

P/E Ratio

Relative Strength

Shape

LMAT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$237M

Shape324%

2025-Revenue

$2.06

Shape289%

2025-EPS

$51M

Shape201%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cantor Fitzgerald

initialise

Previous: Not converted

2024-10-15

Now: Neutral

Oppenheimer

initialise

Previous: Not converted

2023-09-06

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-17%

0.25
vs 0.3

Q4.22

arrow
arrow

-11%

0.25
vs 0.28

Q1.23

arrow
arrow

N/A

0.27
vs 0.27

Q2.23

arrow
arrow

+24%

0.36
vs 0.29

Q3.23

arrow
arrow

+32%

0.33
vs 0.25

Q4.23

arrow
arrow

+52%

0.38
vs 0.25

Q1.24

arrow
arrow

+63%

0.44
vs 0.27

Q2.24

arrow
arrow

+44%

0.52
vs 0.36

Q3.24

arrow
arrow

+32%

0.43
vs 0.33

Q4.24

arrow
arrow

+21%

0.46
vs 0.38

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+2%

39M  vs 38.4M

Q4.22

arrow
arrow

+4%

41M  vs 39.5M

Q1.23

arrow
arrow

+19%

47.1M  vs 39.6M

Q2.23

arrow
arrow

+19%

50.1M  vs 42.1M

Q3.23

arrow
arrow

+21%

47.4M  vs 39M

Q4.23

arrow
arrow

+19%

48.9M  vs 41M

Q1.24

arrow
arrow

+14%

53.5M  vs 47.1M

Q2.24

arrow
arrow

+11%

55.8M  vs 50.1M

Q3.24

arrow
arrow

+13%

53.5M  vs 47.4M

Q4.24

arrow
arrow

+14%

55.5M  vs 48.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+2%

0.02
vs 0.01

Q4.22

arrow
arrow

+2%

0.02
vs 0.02

Q1.23

arrow
arrow

+2%

0.02
vs 0.02

Q2.23

arrow
arrow

+3%

0.03
vs 0.02

Q3.23

arrow
arrow

+3%

0.03
vs 0.03

Q4.23

arrow
arrow

+3%

0.03
vs 0.03

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+4%

0.04
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

187

187
vs 179

4%

Q4.22

arrow
arrow

180

180
vs 187

-4%

Q1.23

arrow
arrow

186

186
vs 180

3%

Q2.23

arrow
arrow

213

213
vs 186

15%

Q3.23

arrow
arrow

221

221
vs 213

4%

Q4.23

arrow
arrow

229

229
vs 221

4%

Q1.24

arrow
arrow

249

249
vs 229

9%

Q2.24

arrow
arrow

260

260
vs 249

4%

Earnings Growth

Latest News